110 related articles for article (PubMed ID: 7523197)
1. Activation of the mouse cytokeratin A (endo A) gene in teratocarcinoma F9 cells by the histone deacetylase inhibitor Trichostatin A.
Miyashita T; Yamamoto H; Nishimune Y; Nozaki M; Morita T; Matsushiro A
FEBS Lett; 1994 Oct; 353(2):225-9. PubMed ID: 7523197
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.
Camarero N; Nadal A; Barrero MJ; Haro D; Marrero PF
Nucleic Acids Res; 2003 Mar; 31(6):1693-703. PubMed ID: 12626711
[TBL] [Abstract][Full Text] [Related]
3. Activation of the gamma-glutamyltransferase promoter 2 in the rat colon carcinoma cell line CC531 by histone deacetylase inhibitors is mediated through the Sp1 binding motif.
Mikkelsen IM; Huseby NE; Visvikis A; Moens U
Biochem Pharmacol; 2002 Jul; 64(2):307-15. PubMed ID: 12123752
[TBL] [Abstract][Full Text] [Related]
4. Gene expression within a chromatin domain: the role of core histone hyperacetylation.
Schlake T; Klehr-Wirth D; Yoshida M; Beppu T; Bode J
Biochemistry; 1994 Apr; 33(14):4197-206. PubMed ID: 8155635
[TBL] [Abstract][Full Text] [Related]
5. Identification of differentiation-dependent DNase I-hypersensitive sites in the mouse EndoA gene.
Miyashita T; Yamamoto H; Takemoto Y; Nozaki M; Morita T; Matsushiro A
Gene; 1993 Mar; 125(2):151-8. PubMed ID: 7681804
[TBL] [Abstract][Full Text] [Related]
6. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression.
Siavoshian S; Segain JP; Kornprobst M; Bonnet C; Cherbut C; Galmiche JP; Blottière HM
Gut; 2000 Apr; 46(4):507-14. PubMed ID: 10716680
[TBL] [Abstract][Full Text] [Related]
7. Histone acetylation influences thyroid hormone and retinoic acid-mediated gene expression.
Garcia-Villalba P; Jimenez-Lara AM; Castillo AI; Aranda A
DNA Cell Biol; 1997 Apr; 16(4):421-31. PubMed ID: 9150429
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional repression of ErbB2 by histone deacetylase inhibitors detected by a genomically integrated ErbB2 promoter-reporting cell screen.
Scott GK; Marden C; Xu F; Kirk L; Benz CC
Mol Cancer Ther; 2002 Apr; 1(6):385-92. PubMed ID: 12477051
[TBL] [Abstract][Full Text] [Related]
9. Glial cell-specific regulation of the JC virus early promoter by histone deacetylase inhibitors.
Kim SY; Woo MS; Kim WK; Choi EC; Henson JW; Kim HS
J Virol; 2003 Mar; 77(6):3394-401. PubMed ID: 12610114
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.
Sowa Y; Orita T; Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
Biochem Biophys Res Commun; 1997 Dec; 241(1):142-50. PubMed ID: 9405248
[TBL] [Abstract][Full Text] [Related]
11. Effects of trichostatin A on neuronal mu-opioid receptor gene expression.
Lin YC; Flock KE; Cook RJ; Hunkele AJ; Loh HH; Ko JL
Brain Res; 2008 Dec; 1246():1-10. PubMed ID: 18950606
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors promote ATP2A3 gene expression in hepatocellular carcinoma cells: p300 as a transcriptional regulator.
Hernández-Oliveras A; Izquierdo-Torres E; Meneses-Morales I; Rodríguez G; Zarain-Herzberg Á; Santiago-García J
Int J Biochem Cell Biol; 2019 Aug; 113():8-16. PubMed ID: 31146004
[TBL] [Abstract][Full Text] [Related]
13. HDAC inhibitors TSA and sodium butyrate enhanced the human IL-5 expression by altering histone acetylation status at its promoter region.
Han S; Lu J; Zhang Y; Cheng C; Li L; Han L; Huang B
Immunol Lett; 2007 Feb; 108(2):143-50. PubMed ID: 17270283
[TBL] [Abstract][Full Text] [Related]
14. Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase.
Chen WY; Bailey EC; McCune SL; Dong JY; Townes TM
Proc Natl Acad Sci U S A; 1997 May; 94(11):5798-803. PubMed ID: 9159154
[TBL] [Abstract][Full Text] [Related]
15. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors.
McBain JA; Eastman A; Nobel CS; Mueller GC
Biochem Pharmacol; 1997 May; 53(9):1357-68. PubMed ID: 9214697
[TBL] [Abstract][Full Text] [Related]
16. Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex.
Walker GE; Wilson EM; Powell D; Oh Y
Endocrinology; 2001 Sep; 142(9):3817-27. PubMed ID: 11517158
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of IL-2 gene expression by trichostatin A, a potent inhibitor of mammalian histone deacetylase.
Takahashi I; Miyaji H; Yoshida T; Sato S; Mizukami T
J Antibiot (Tokyo); 1996 May; 49(5):453-7. PubMed ID: 8682722
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothelial cells involves histone acetylation.
Arts J; Lansink M; Grimbergen J; Toet KH; Kooistra T
Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):171-6. PubMed ID: 7646441
[TBL] [Abstract][Full Text] [Related]
19. Sp1 and chromatin environment are important contributors to the formation of repressive chromatin structures on the transfected human adenine nucleotide translocase-2 promoter.
Hodny Z; Li R; Barath P; Nelson BD
Biochem J; 2000 Feb; 346 Pt 1(Pt 1):93-7. PubMed ID: 10657244
[TBL] [Abstract][Full Text] [Related]
20. Effects of histone deacetylase inhibitors on estradiol-induced proliferation and hyperplasia formation in the mouse uterus.
Gunin AG; Kapitova IN; Suslonova NV
J Endocrinol; 2005 Jun; 185(3):539-49. PubMed ID: 15930180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
